cAMPfield Therapeutics is a biotechnology research company headquartered in San Diego, California. The company focuses on discovering and developing innovative therapeutic treatments targeting specific biological pathways.
Subscribe to see cAMPfield Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
cAMPfield Therapeutics is a biotechnology company headquartered in United States. Its most recent funding round, Series A, raised $180M in June 2026. Xcout tracks 8 named people at cAMPfield Therapeutics, including Bill Gerhart (Chief Executive Officer).
2 more named people on record for cAMPfield Therapeutics, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $180M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of cAMPfield Therapeutics's closest competitors — see the full list of competitors and alternatives →
Crystalys Therapeutics is a biotechnology research company headquartered in San Diego, California, dedicated to developing novel therapies to address significant unmet medical needs.
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
ACEA Therapeutics, Inc. is a biopharmaceutical company committed to improving healthcare and treatments, headquartered in San Diego, California.
Cellics Therapeutics, Inc. is a privately held biotechnology company headquartered in San Diego, California, developing novel therapeutic products.
Abilita Therapeutics, Inc. is a privately held biotechnology company founded in 2014 and focused on redefining therapeutics. The company is headquartered in San Diego, California.
RayThera is a small molecule drug discovery company founded in August 2023, headquartered in San Diego, CA, United States. Its mission is to develop safer, more effective therapeutics by advancing drug discovery with proven expertise and adaptable approaches. The company focuses on transformative therapies for unmet medical needs.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.